Clinical Trials in New York State

Showing 7341-7360 of 17,167 trials

Clinical Performance of Senofilcon A Investigational Lens

NCT05300763

This study is a controlled, randomized, subject-masked, 2-arm parallel, 2-week dispensing, bilateral evaluation where the study lenses are worn for a minimum of 5 days per week and 6 hours per day.

Visual Acuity

Johnson & Johnson Vision Care, Inc.344 participantsStarted Mar 2022

San Francisco, California, United States • Jacksonville, Florida, United States • Jacksonville, Florida, United States +16 more locations

COMPLETEDPhase 269 miles

Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia

NCT00003808

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of theophylline in treating patients who have in situ, stage I, or stage II chronic lymphocytic leukemia.

Leukemia

Eastern Cooperative Oncology GroupStarted Aug 1999

Scottsdale, Arizona, United States • Los Angeles, California, United States • Palo Alto, California, United States +68 more locations

Clinical Performance of Senofilcon A Investigational Lens

Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia

Find Trials by Condition in New York State

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach

Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma

Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)

Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib

A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis

BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

Phantom Motor Execution Via MPR, VR/AR, and SG, as a Treatment of PLP